Clinical Trials Find Success with Use of Next-Generation Gene Sequencing; Could Lead to More Precise Clinical Pathology Laboratory Tests
Pathologists and medical lab scientists may do more consults with interdisciplinary teams in connection with biomarker-based phase I clinical trial selection
Scientists are beginning to incorporate next-generation gene sequencing into a growing number of clinical trials. This is an important development because knowledge developed in clinical trials often forms the foundation for the evidence-based medicine guidelines issued following a successful clinical trial.
Further, these new uses for gene sequencing can directly lead to new opportunities for clinical laboratories and pathology groups. That’s because the increased use of gene sequencing for patients participating in clinical trials may well provide the necessary evidence to support new molecular diagnostics assays and genetic tests that physicians would use in support of therapeutic drugs cleared for market. (more…)